---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-029429"
form_type: "8-K"
ticker: "RZLT"
cik: "0001509261"
company_name: "Rezolute, Inc."
filed_at: "2025-03-28T23:59:59+00:00"
generated_at: "2026-05-24T03:01:25.086879+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Rezolute appoints Erik Harris to board of directors effective March 25, 2025

## Summary
- Erik Harris elected to board effective March 25, 2025; determined independent under Nasdaq rules.
- Harris is CCO and EVP at Ultragenyx Pharmaceutical since June 2019; previously VP at InterMune, Crescendo Bioscience.
- Will receive standard non-employee director cash retainer (pro-rated) and 60,000 stock options at $2.89 exercise price.
- Options vest monthly from March 25, 2025, expiring March 25, 2035; committee assignments pending.
- No family relationships with directors/officers and no material interest in transactions required to disclose.

## SEC filing metadata
- accession: 0001104659-25-029429
- form_type: 8-K
- ticker: RZLT
- cik: 0001509261
- company_name: Rezolute, Inc.
- filed_at: 2025-03-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1509261/000110465925029429/0001104659-25-029429-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1509261/000110465925029429/tm2510754d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-029429
- JSON: https://secwatch.observer/filing/0001104659-25-029429.json
- Plain text: https://secwatch.observer/filing/0001104659-25-029429.txt

## Key facts
- Executive change
  Erik Harris was elected as Director at Rezolute, Inc..
  - Action: elected
  - Role: Director
  source text: On March 25, 2025, the Board of Directors (the “Board”) of Rezolute, Inc. (the “Company”) upon the recommendation of the Company’s nominating and corporate governance committee elected Erik Harris to the Board, effective March 25, 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1509261/000110465925029429/0001104659-25-029429-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.